In vitro activity of a new antibacterial rhodanine derivative against Staphylococcus epidermidis biofilms

Size: px
Start display at page:

Download "In vitro activity of a new antibacterial rhodanine derivative against Staphylococcus epidermidis biofilms"

Transcription

1 Journal of Antimicrobial Chemotherapy (2006) 58, doi: /jac/dkl314 Advance Access publication 30 July 2006 In vitro activity of a new antibacterial rhodanine derivative against Staphylococcus epidermidis biofilms Maxime Gualtieri 1, Lionel Bastide 2, Philippe Villain-Guillot 1, Sylvie Michaux-Charachon 3,4, Jaqueline Latouche 1 and Jean-Paul Leonetti 1 * 1 CNRS UMR 5160, Centre de Pharmacologie et Biotechnologie pour la Santé, Faculté de Pharmacie, Montpellier, France; 2 Selectbiotics, Nîmes, France; 3 INSERM U-431, Faculté de Médecine, Nîmes, France; 4 Laboratoire de Bactériologie, CHU de Nîmes, Nîmes, France Introduction Received 24 April 2006; returned 8 June 2006; revised and accepted 7 July 2006 bjectives: Staphylococcus epidermidis biofilms form at the surface of implants and prostheses and are responsible for the failure of many antibiotic therapies. nly a few antibiotics are relatively active against biofilms, and rifampicin, a transcription inhibitor, is among the most effective molecules for treating biofilm-related infections. Having recently selected a new potential transcription inhibitor, we attempted to evaluate its efficacy against S. epidermidis biofilms. Methods: Biofilm-forming S. epidermidis strains were grown planktonically or as biofilms and their susceptibility to this transcription inhibitor was compared with reference antibiotics with different mechanisms of action. Conclusions: ur results demonstrate that this new molecule is active; its effects are fast and kinetically related to those of rifampicin, but unlike rifampicin it does not select for resistant bacteria. Keywords: RNA polymerase, inhibitors, antibiotics Biofilm-related infections are very common nosocomial infections 1 4 and account for significant morbidity and mortality. Biofilms are formed by the colonization of solid supports (bones, implants and catheters) by adherent bacteria. Several mechanisms have been proposed to explain why only very few molecules are active against biofilms: biofilm-embedded bacteria enter a nongrowing (stationary) state, in which they are less susceptible to growth-dependent antimicrobial killing, 5 physicochemical interaction of certain antibiotics with slime 6 and lower diffusion, 7,8 or changes in the bacterial envelope following adhesion. However, the presence in the biofilms at a high frequency of persisters, bacteria that do not grow but do not die in the presence of the antibiotic, might be the cause of these recalcitrant infections. 9 Vancomycin, for example, is often used to treat biofilm-related infections because of the frequent occurrence of methicillinresistant coagulase-negative staphylococci, but its efficacy is low within a biofilm. Consequently, vancomycin must be used in association with other molecules. n the other hand, despite its tendency to trigger the appearance of resistance, the efficacy of rifampicin in treating bacteria adhered to biomaterials has been broadly demonstrated in vitro 10 and in clinical trials. 11 Rifampicin derivatives with high antistaphylococcal activity are among the most lipophilic antibiotics. Their association with other lipophilic bacteriostatic agents such as erythromycin and fusidic acid results in antimicrobial activities far more effective than the individual agents against non-growing bacteria. 12 We have recently selected relatively hydrophobic new bactericidal agents that inhibit transcription in enzymatic studies and affect bacterial RNA synthesis. 13 These molecules are active in the micromolar range against planktonic bacteria. Unlike rifampicin, which triggers the appearance of resistance due to point mutation at the surface of the polymerase, these molecules are far less likely to select resistance. We describe here our investigation of the efficacy of one of them, called SB13 (Figure 1), against biofilms of Staphylococcus epidermidis. Materials and methods Bacterial strains and antimicrobial agents S. epidermidis reference strains ATCC (RP62A) and DSM 3269 and two clinical isolates (strains and 48155) obtained from patients with staphylococcal infection at the University Hospital of Nîmes were used. All four isolates were chosen for their ability to... *Corresponding author. Tel: ; Fax: ; jp.leonetti@cpbs.univ-montp1.fr Ó The Author Published by xford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please journals.permissions@oxfordjournals.org

2 RNA polymerase inhibitors active on biofilms H Table 1. MICs and MBCs of SB13 and reference antibiotics determined by the broth microdilution method for planktonic S. epidermidis (ATCC 35984) Antibiotic MIC (mg/l) MBC (mg/l) Figure 1. Structure of SB13. form a biofilm. The following antimicrobial agents belonging to different antibiotic classes were selected, most of them for their common use in human medicine: rifampicin (Sigma-Aldrich), vancomycin (Sigma-Aldrich), minocycline (Sigma-Aldrich), fusidic acid (Sigma-Aldrich), novobiocin (Sigma-Aldrich), fosfomycin (Sigma-Aldrich), a mixture of amoxicillin (84%)/clavulanic acid (16%) (AugmentinÒ, GlaxoSmithKline), a mixture of imipenem (50%)/cilastatin (50%) (TienamÒ, Merck Sharp and Dohme Chibret) and SB13 (Chembridge Corp., San Diego, CA, USA). Susceptibility testing methods MICs were determined as recommended by the CLSI. 14 Antibiotics were tested at final concentrations (prepared from serial 2-fold dilutions) ranging from 20 to mg/l. The MIC was defined as the lowest antibiotic concentration that yielded no visible growth. The test medium was Mueller Hinton broth (MHB) and the inoculum was cfu/ml. The inoculated microplates were incubated at 37 C for 18 h before reading. MBCs were established by extending the MIC procedure to the evaluation of bactericidal activity. After 24 h, 10 ml was drawn from the wells, serially diluted and then spotted onto suitable agar plates. The plates were incubated at 37 C overnight. The MBC read 18 h later was defined as the lowest concentration of antibiotic that resulted in 0.1% survival in the subculture. All the experiments were performed in triplicate. The results are summarized in Table 1. Growth of biofilms in 96-well polystyrene microtitre plates The wells of 96-well polystyrene microtitre plates (Falcon Microtest TM ) were filled with 0.1 ml aliquots of S. epidermidis inoculum (10 7 cfu/ml), and the plates were incubated for 24 h at 37 C. The wells were rinsed twice with 0.2 ml of sterile water to discard non-adherent bacteria. Subsequently, 0.1 ml of MHB containing the desired antibiotic concentration was added to the wells and the plates were incubated at 37 C for 1 24 h without shaking. After the challenge, the plates were washed twice with sterile water and then 0.1 ml of MHB was added. Adherent bacteria were sonicated with a Branson 450 Sonifier with a microtip (4 2 s, 10% of the maximal amplitude) and bacteria were quantified by a serial dilution method. Aliquots were spotted onto MHB-agar plates. The plates were incubated at 37 C for 24 h before counting. All the experiments were performed in triplicate. Antibiotic combination study on biofilms S Twenty-four hours after biofilm formation, the biofilms were washed twice with sterile water. Subsequently 0.1 ml of MHB containing S N SB Rifampicin Fosfomycin Vancomycin Minocycline Fusidic acid Novobiocin Amoxicillin/clavulanic acid Imipenem/cilastatin antibiotics 1 and 2 at 0.5, 1, 2 and 4 MIC was added to the wells. The plates were incubated at 37 C for 24 h without shaking. They were then processed as described above. All the experiments were performed in triplicate. Results The bacterial strain ATCC used in the study is known for its ability to colonize solid supports such as plastic culture dishes and catheters and has been already tested by numerous laboratories. 15,16 Preliminary control experiments demonstrated unambiguously that this adherent strain generated reproductively a bacterial count about 100-fold greater than non-adherent S. epidermidis strains (data not shown). The dose-dependent effects of control antibiotics and SB13 incubated on 24 h biofilms were evaluated first. As shown in Table 2, only rifampicin and SB13 decreased the bacterial count by more than 3 log 10 U. At 20 mg/l, amoxicillin/clavulanic acid or imipenem/cilastatin had little or no activity, whereas fosfomycin, fusidic acid, vancomycin, novobiocin and minocycline had intermediate activity. It is commonly accepted that biofilms become more resistant to antibiotics with ageing. 17 Six hour biofilms generally respond well in vitro to the treatment, but resistance increases at 24 and 48 h. We did not attempt to evaluate the effects of SB13 on 6 h biofilms because they behave more like planktonic bacteria than true biofilms. However the comparison between 24 and 48 h biofilms correlates with data from the literature. When the age of the biofilm increased, the biofilms became more resistant and the effects of all the antibiotics tested became negligible (data not shown). In order to investigate the time dependence of the activity of rifampicin and SB13, the biofilms were incubated for an increased period of time with these molecules (Tables 3 and 4). The kinetics of action of SB13 were slower than those of rifampicin. After a 3 h challenge with 8 MIC, reductions of 1.79 and 3.7 log 10 Uof the bacterial counts were observed for SB13 and rifampicin, respectively. However, at 8 MIC and treatment for 24 h, SB13 and rifampicin decreased the bacterial viability respectively by more than 3.9 and 3.14 log 10 U (Figure 2). Despite the fact that SB13 exhibited the highest MIC of the antibiotics tested, it was the most efficient molecule on biofilm after rifampicin in terms of concentration and the best molecule in terms of the reduction of the bacterial count. 779

3 Gualtieri et al. Table 2. Effects of SB13 and references antibiotics incubated for 24 h with an S. epidermidis (ATCC 35984) biofilm Imipenem/ cilastatin Amoxicillin/ clavulanic acid Antibiotic concentration (mg/l) SB13 Rifampicin Fosfomycin Vancomycin Minocycline Fusidic acid Novobiocin a a Mean value standard error of the difference in log10 cfu/ml between untreated and treated samples observed in 24 h S. epidermidis (ATCC ) biofilms. Antibiotic combinations are often necessary in the treatment of S. epidermidis infection. 17 These combinations are used in treatments involving rifampicin to avoid the appearance of rifampicin resistance. The combinations can also enhance the effects of individual antimicrobial agents by synergic action. When we used 96-well plates to challenge the biofilm with rifampicin and SB13 for several days, no resistant bacteria were selected (data not shown). However, when 6-well plates were used, the decrease of the bacterial count was only transient with rifampicin, whereas it was stable with SB13. This result can account for the fact that the number of bacteria present in the 6-well plates was greater then in the 96-well plates and that spontaneous rifampicin-resistant bacteria were selected. Under the same conditions, SB13 did not select any resistant bacteria (Table 5). When we tested different antibiotic combinations (Table 6), the strongest synergic effect was observed with SB13 and vancomycin, the difference being attributed to synergy that reached 1.21 log 10 U followed by SB13 and imipenem/cilastatin (difference = 0.68 log 10 U) and amoxicillin/clavulanic acid (difference = 0.58 log 10 U). It was striking to notice that most of the antibiotics synergic or antagonistic with rifampicin behaved similarly when combined with SB13. A comparison of the effects of SB13 on three other S. epidermidis strains, another reference strain and two strains isolated from catheters, demonstrated that these observations were not restricted to the model strain (Table 7). SB13 decreased the amount of viable bacteria by 3 4 log 10 U after a 24 h treatment. Discussion SB13 is a member of a family of synthetic molecules with strong bactericidal properties and low toxicity. 13 It inhibits transcription in enzymatic assays and selectively inhibits bacterial RNA synthesis. 13 Due to the absence of spontaneous resistant mutants, 13 we cannot exclude that this relatively hydrophobic molecule targets additional proteins. However, the fast and selective transcription inhibition by SB13 observed in vivo and the similarities between the bactericidal kinetics of rifampicin and SB13 on planktonic bacteria are encouraging facts. 13 We attempted to compare the activity of rifampicin with that of SB13 and reference antibiotics on S. epidermidis biofilms. It has been suggested that the protein target could be the major determinant of antibiotic efficacy against biofilms 18 and that molecules affecting cell wall synthesis are among the least efficient. It is also clear that rifampicin is one of the best molecules for eradicating S. epidermidis. 10,18,19 Due to its very low MIC, rifampicin is more active in the present study than SB13 in terms of concentration. However at a concentration close to its MIC and comparable to the antibiotic concentration often used in the literature on biofilms 10,18 SB13 is as efficient as rifampicin. This confirms that antibiotics targeting transcription do not differ in their efficacy against biofilms. To our knowledge this is the first comparison of two transcription inhibitors with different structures and more detailed studies with other inhibitors are ongoing. Incidentally, we also observed that molecules targeting different proteins involved in cell synthesis can differ strongly in their efficacy to eradicate the biofilm. Vancomycin and fusidic acid decreased the bacterial counts by 2 3 log 10 U, while mixtures 780

4 RNA polymerase inhibitors active on biofilms Table 3. Time dependence of the activity of SB13 against S. epidermidis (ATCC 35984) biofilm SB13 concentration (mg/l ) MIC 1 h 3 h 6 h 12 h 24 h a a Mean value standard error of the difference in log 10 cfu/ml between untreated and treated samples observed in 24 h S. epidermidis (ATCC 35984) biofilms. Table 4. Time dependence of the activity of rifampicin against S. epidermidis (ATCC 35984) biofilm Rifampicin concentration (mg/l) MIC 1 h 3 h 6 h 12 h 24 h a a Mean value standard error of the difference in log 10 cfu/ml between untreated and treated samples observed in 24 h S. epidermidis (ATCC 35984) biofilms. Table 5. Comparison of the propensity of SB13 and rifampicin to select spontaneous resistant mutants on an S. epidermidis (ATCC 35984) biofilm Antibiotic treatment duration Antibiotic (20 mg/l) 24 h 48 h 120 h 168 h 216 h Rifampicin a SB a Mean value standard error of the difference in log 10 cfu/ml between untreated and treated samples observed in 24 h S. epidermidis (ATCC 35984) biofilms. of amoxicillin/clavulanic acid or imipenem/cilastatin demonstrated poor efficacy. When used in combination with several other antibiotics, we also observed that most of the antibiotics that are synergic or antagonistic with rifampicin behave similarly with SB13. This suggests that a similar mechanism of action leads to similar synergism or antagonism between these two molecules. The synergic effect of a combination between rifampicin and vancomycin on a biofilm has already been documented 10,19 and we extend it to our new transcription inhibitor. A major advantage of this molecule, when compared with rifampicin, is the absence of selection of resistant mutants. We previously attempted to select spontaneous resistant mutants to SB13 at a concentration of 3 MIC without success, suggesting 781

5 Gualtieri et al. Difference between untreated and treated samples log 10 cfu/ml Antibiotic concentration ( MIC) Figure 2. Effect of antibiotics at different concentrations on 24 h S. epidermidis (ATCC 35984) biofilms treated for 24 h. pen diamonds, vancomycin; filled squares, minocycline; filled triangles, fusidic acid; open circles, novobiocin; open squares, SB13; filled diamonds, rifampicin; filled circles, amoxicillin/clavulanic acid; open triangles, imipenem/cilastatin. Table 6. Comparison of the effects of SB13 and rifampicin in combination with reference antibiotics on S. epidermidis (ATCC 35984) biofilm Antibiotic combination (antibiotic 1 + antibiotic 2) Antibiotic concentration Sum of D values of the individual antibiotics D value for the combination SB13 + vancomycin MIC 0.30 a 0.67 b 2 MIC MIC Rifampicin + vancomycin 0.5 MIC MIC MIC MIC SB13 + amoxicillin/ MIC clavulanic acid 2 MIC Rifampicin + amoxicillin/ clavulanic acid SB13 + imipenem/ cilastatin Rifampicin + imipenem/cilastatin 4 MIC MIC MIC MIC MIC MIC MIC MIC MIC MIC MIC a Sum of D1 + D2. D1 = mean value standard error of the difference in log 10 cfu/ml between untreated and treated samples with antibiotic 1 (SB13 or rifampicin) observed in 24 h S. epidermidis (ATCC 35984) biofilms. D2 = mean value standard error of the difference in log 10 cfu/ml between untreated and treated samples with antibiotic 2 observed in 24 h S. epidermidis (ATCC 35984) biofilms. b Mean value standard error of the difference in log 10 cfu/ml between untreated and treated samples with antibiotic combination (antibiotic 1 + antibiotic 2) observed in 24 h S. epidermidis (ATCC 35984) biofilms. Table 7. Effects of SB13 on the reference S. epidermidis (ATCC 35984) biofilm and on three S. epidermidis clinical isolates SB13 concentration (mg/l) a mutation frequency lower than We also failed to isolate resistant bacteria by slow adaptation at subinhibitory concentrations (not shown). In a biofilm and under the same conditions, rifampicin selects resistant bacteria that rapidly re-colonize the surface of the plate. ur study suggests that antibiotics with the same target but having different molecular weights and hydrophobicity do not differ in their efficacy against biofilm cells, and we confirm that these new molecules present a strong interest. Data on the peak serum concentration of this molecule are still missing, but the relative hydrophobicity of SB13 and its binding to serum proteins precludes for now systemic uses and topical applications are under evaluation. Modifications are also ongoing to decrease this binding to serum proteins. Strikingly, very few transcription inhibitors have been tested on biofilms and other molecules such as lipiarmycin, a macrocyclic antibiotic currently under development under the name of PT-80 (ptimer Pharmaceuticals, Inc., San Diego, CA, USA), should be evaluated. Acknowledgements We thank Dr S. L. Salhi for the editorial revision of the manuscript. This work was supported by institutional funds from the Centre National de la Recherche Scientifique and the Grant Biosécurité Transparency declarations J.-P. L. receives research support from Selectbiotics, and Lionel bastide is researcher for Selectbiotics. References Strain ATCC DSM a a Mean value standard error of the difference in log 10 cfu/ml between untreated and treated samples observed in different 24 h S. epidermidis biofilms. 1. Gara JP, Humphreys H. Staphylococcus epidermidis biofilms: importance and implications. J Med Microbiol 2001; 50: von Eiff C, Peters G, Heilmann C et al. Pathogenesis of infections due to coagulase negative staphylococci. Lancet Infect Dis 2002; 2: Costerton JW, Stewart PS, Greenberg EP et al. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284: Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002; 15: Gilbert P, Collier PJ, Brown MRW et al. Influence of growth rate on susceptibility to antimicrobial agents: biofilms, cell cycle, dormancy, and stringent response. Antimicrob Agents Chemother 1990; 34: Gordon CA, Hodges NA, Marriott C et al. Antibiotic interaction and diffusion through alginate and exopolysaccharide of cystic 782

6 RNA polymerase inhibitors active on biofilms fibrosis-derived Pseudomonas aeruginosa. J Antimicrob Chemother 1988; 22: Hoyle BD, Alcantara J, Costerton JW et al. Pseudomonas aeruginosa biofilm as a diffusion barrier to piperacillin. Antimicrob Agents Chemother 1992; 36: Dunne W, Mason E, Kaplan SL et al. Diffusion of rifampin and vancomycin through a Staphylococcus epidermidis biofilm. Antimicrob Agents Chemother 1993; 37: Keren I, Kaldalu N, Spoering A et al. Persister cells and tolerance to antimicrobials. FEMS Microbiol Let 2004; 230: Saginur R, Stdenis M, Ferris W et al. Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections. Antimicrob Agents Chemother 2006; 50: Marciante KD, Veenstra DL, Lipsky BA et al. Which antimicrobial impregnated central venous catheter should we use? Modeling the costs and outcomes of antimicrobial catheter use. Am J Infect Control 2003; 31: Raad I, Darouiche R, Hachem R et al. Antibiotics and prevention of microbial colonization of catheters. Antimicrob Agents Chemother 1995; 39: André E, Bastide L, Michaux-Charachon S et al. Novel synthetic molecules targeting the bacterial RNA polymerase assembly. J Antimicrob Chemother 2006; 57: National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically Sixth Edition: Approved Standard M07-A6. PA, USA: NCCLS, Villanova, Curtin J, Cormican M, Fleming G et al. Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections. Antimicrob Agents Chemother 2003; 47: Svensson E, Hanberger H, Nilsson M et al. Factors affecting development of rifampicin resistance in biofilm-producing Staphylococcus epidermidis. J Antimicrob Chemother 1997; 39: Anwar H, Srap JP, Costerton JW et al. Establishment of aging biofilms: possible mechanism of bacterial resistance to antimicrobial therapy. Antimicrob Agents Chemother 1992; 36: Cerca N, Martins S, Cerca F et al. Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry. J Antimicrob Chemother 2005; 56: Peck KR, Kim SW Jung SI et al. Antimicrobials as potential adjunctive agents in the treatment of biofilm infection with Staphylococcus epidermidis. Chemotherapy 2003; 49:

Tel: Fax:

Tel: Fax: CONCISE COMMUNICATION Bactericidal activity and synergy studies of BAL,a novel pyrrolidinone--ylidenemethyl cephem,tested against streptococci, enterococci and methicillin-resistant staphylococci L. M.

More information

2 0 hr. 2 hr. 4 hr. 8 hr. 10 hr. 12 hr.14 hr. 16 hr. 18 hr. 20 hr. 22 hr. 24 hr. (time)

2 0 hr. 2 hr. 4 hr. 8 hr. 10 hr. 12 hr.14 hr. 16 hr. 18 hr. 20 hr. 22 hr. 24 hr. (time) Key words I μ μ μ μ μ μ μ μ μ μ μ μ μ μ II Fig. 1. Microdilution plate. The dilution step of the antimicrobial agent is prepared in the -well microplate. Serial twofold dilution were prepared according

More information

Selective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016

Selective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016 Selective toxicity Antimicrobial Drugs Chapter 20 BIO 220 Drugs must work inside the host and harm the infective pathogens, but not the host Antibiotics are compounds produced by fungi or bacteria that

More information

Impact of Spores on the Comparative Efficacies of Five Antibiotics. Pharmacodynamic Model

Impact of Spores on the Comparative Efficacies of Five Antibiotics. Pharmacodynamic Model AAC Accepts, published online ahead of print on 12 December 2011 Antimicrob. Agents Chemother. doi:10.1128/aac.01109-10 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions.

More information

Should we test Clostridium difficile for antimicrobial resistance? by author

Should we test Clostridium difficile for antimicrobial resistance? by author Should we test Clostridium difficile for antimicrobial resistance? Paola Mastrantonio Department of Infectious Diseases Istituto Superiore di Sanità, Rome,Italy Clostridium difficile infection (CDI) (first

More information

Evaluation of antimicrobial activity of certain combinations of antibiotics against in vitro Staphylococcus epidermidis biofilms

Evaluation of antimicrobial activity of certain combinations of antibiotics against in vitro Staphylococcus epidermidis biofilms Indian J Med Res 135, April 2012, pp 542-547 Evaluation of antimicrobial activity of certain combinations of antibiotics against in vitro Staphylococcus epidermidis biofilms Fernanda Gomes, Pilar Teixeira,

More information

Journal of Antimicrobial Chemotherapy Advance Access published August 26, 2006

Journal of Antimicrobial Chemotherapy Advance Access published August 26, 2006 Journal of Antimicrobial Chemotherapy Advance Access published August, Journal of Antimicrobial Chemotherapy doi:./jac/dkl Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae,

More information

Principles of Antimicrobial therapy

Principles of Antimicrobial therapy Principles of Antimicrobial therapy Laith Mohammed Abbas Al-Huseini M.B.Ch.B., M.Sc, M.Res, Ph.D Department of Pharmacology and Therapeutics Antimicrobial agents are chemical substances that can kill or

More information

MICHAEL J. RYBAK,* ELLIE HERSHBERGER, TABITHA MOLDOVAN, AND RICHARD G. GRUCZ

MICHAEL J. RYBAK,* ELLIE HERSHBERGER, TABITHA MOLDOVAN, AND RICHARD G. GRUCZ ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 2000, p. 1062 1066 Vol. 44, No. 4 0066-4804/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. In Vitro Activities of Daptomycin,

More information

Introduction to Pharmacokinetics and Pharmacodynamics

Introduction to Pharmacokinetics and Pharmacodynamics Introduction to Pharmacokinetics and Pharmacodynamics Diane M. Cappelletty, Pharm.D. Assistant Professor of Pharmacy Practice Wayne State University August, 2001 Vocabulary Clearance Renal elimination:

More information

Antibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017

Antibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017 Antibiotics Antimicrobial Drugs Chapter 20 BIO 220 Antibiotics are compounds produced by fungi or bacteria that inhibit or kill competing microbial species Antimicrobial drugs must display selective toxicity,

More information

Brief reports. Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae

Brief reports. Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae Journal of Antimicrobial Chemotherapy (1997) 40, 105 108 Brief reports JAC Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae Andreas Pikis a *, Jacob A. Donkersloot

More information

QUESTION 11: What is the relevance of Minimum Inhibitory Concentration (MIC) of infecting organisms in biofilm-mediated chronic infection?

QUESTION 11: What is the relevance of Minimum Inhibitory Concentration (MIC) of infecting organisms in biofilm-mediated chronic infection? QUESTION 11: What is the relevance of Minimum Inhibitory Concentration (MIC) of infecting organisms in biofilm-mediated chronic infection? Authors: Jeppe Lange, Matthew Scarborough, Robert Townsend Response:

More information

Biofilm eradication studies on uropathogenic E. coli using ciprofloxacin and nitrofurantoin

Biofilm eradication studies on uropathogenic E. coli using ciprofloxacin and nitrofurantoin Available online at www.pharmscidirect.com Int J Pharm Biomed Res 212, 3(2), 127-131 Research article International Journal of PHARMACEUTICAL AND BIOMEDICAL RESEARCH ISSN No: 976-35 Biofilm eradication

More information

Influence of ph on Adaptive Resistance of Pseudomonas aeruginosa to Aminoglycosides and Their Postantibiotic Effects

Influence of ph on Adaptive Resistance of Pseudomonas aeruginosa to Aminoglycosides and Their Postantibiotic Effects ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Jan. 1996, p. 35 39 Vol. 40, No. 1 0066-4804/96/$04.00 0 Copyright 1996, American Society for Microbiology Influence of ph on Adaptive Resistance of Pseudomonas aeruginosa

More information

International Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-2, 2017, 1-7 Research Article Open Access.

International Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-2, 2017, 1-7 Research Article Open Access. I J A P B International Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-2, 2017, 1-7 Research Article Open Access. ISSN: 2454-8375 COMPARISON OF ANTIMICROBIAL ACTIVITY AND MIC OF BRANDED

More information

مادة االدوية المرحلة الثالثة م. غدير حاتم محمد

مادة االدوية المرحلة الثالثة م. غدير حاتم محمد م. مادة االدوية المرحلة الثالثة م. غدير حاتم محمد 2017-2016 ANTIMICROBIAL DRUGS Antimicrobial drugs Lecture 1 Antimicrobial Drugs Chemotherapy: The use of drugs to treat a disease. Antimicrobial drugs:

More information

Mastitis cows and immunization

Mastitis cows and immunization In Spain, the antibiotherapy against mastitis moves 12,000,000 with an interannual growth of 10.2%. Only 4 of these millions are drying antibiotherapy. Conclusion: farmers spend a lot of money on mastitis

More information

European Committee on Antimicrobial Susceptibility Testing

European Committee on Antimicrobial Susceptibility Testing European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The

More information

JAC Bactericidal index: a new way to assess quinolone bactericidal activity in vitro

JAC Bactericidal index: a new way to assess quinolone bactericidal activity in vitro Journal of Antimicrobial Chemotherapy (1997) 39, 713 717 JAC Bactericidal index: a new way to assess quinolone bactericidal activity in vitro Ian Morrissey* Department of Biosciences, Division of Biochemistry

More information

Antibacterial activity of Stephania suberosa extract against methicillin-resistant Staphylococcus aureus

Antibacterial activity of Stephania suberosa extract against methicillin-resistant Staphylococcus aureus B-O-021 Antibacterial activity of Stephania suberosa extract against methicillin-resistant Staphylococcus aureus Nongluk Autarkool *a, Yothin Teethaisong a, Sajeera Kupittayanant b, Griangsak Eumkeb a

More information

Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals

Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals J Vet Diagn Invest :164 168 (1998) Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals Susannah K. Hubert, Phouc Dinh Nguyen, Robert D. Walker Abstract.

More information

Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants.

Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants. Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants. C. difficile rarely causes problems, either in healthy adults or in infants.

More information

Title: N-Acetylcysteine (NAC) Mediated Modulation of Bacterial Antibiotic

Title: N-Acetylcysteine (NAC) Mediated Modulation of Bacterial Antibiotic AAC Accepts, published online ahead of print on June 00 Antimicrob. Agents Chemother. doi:0./aac.0070-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights

More information

Synergism of penicillin or ampicillin combined with sissomicin or netilmicin against enterococci

Synergism of penicillin or ampicillin combined with sissomicin or netilmicin against enterococci Journal of Antimicrobial Chemotherapy (78) 4, 53-543 Synergism of penicillin or ampicillin combined with sissomicin or netilmicin against enterococci Chatrchal Watanakunakoni and Cheryl Glotzbecker Infectious

More information

Antimicrobials & Resistance

Antimicrobials & Resistance Antimicrobials & Resistance History 1908, Paul Ehrlich - Arsenic compound Arsphenamine 1929, Alexander Fleming - Discovery of Penicillin 1935, Gerhard Domag - Discovery of the red dye Prontosil (sulfonamide)

More information

Antibacterial susceptibility testing

Antibacterial susceptibility testing Antibiotics: Antil susceptibility testing are natural chemical substances produced by certain groups of microorganisms (fungi, ) that inhibit the growth of or kill the other that cause infection. Several

More information

January 2014 Vol. 34 No. 1

January 2014 Vol. 34 No. 1 January 2014 Vol. 34 No. 1. and Minimum Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) Broth dilution: cation-adjusted Mueller-Hinton

More information

Advance Access published September 16, 2004

Advance Access published September 16, 2004 Advance Access published September 16, 2004 Journal of Antimicrobial Chemotherapy DOI: 10.1093/jac/dkh435 JAC Post-antibiotic effect induced by an antibiotic combination: influence of mode, sequence and

More information

Dynamic Drug Combination Response on Pathogenic Mutations of Staphylococcus aureus

Dynamic Drug Combination Response on Pathogenic Mutations of Staphylococcus aureus 2011 International Conference on Biomedical Engineering and Technology IPCBEE vol.11 (2011) (2011) IACSIT Press, Singapore Dynamic Drug Combination Response on Pathogenic Mutations of Staphylococcus aureus

More information

Received 5 February 2004/Returned for modification 16 March 2004/Accepted 7 April 2004

Received 5 February 2004/Returned for modification 16 March 2004/Accepted 7 April 2004 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 2004, p. 3112 3118 Vol. 48, No. 8 0066-4804/04/$08.00 0 DOI: 10.1128/AAC.48.8.3112 3118.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved.

More information

Performance Information. Vet use only

Performance Information. Vet use only Performance Information Vet use only Performance of plates read manually was measured in three sites. Each centre tested Enterobacteriaceae, streptococci, staphylococci and pseudomonas-like organisms.

More information

European Committee on Antimicrobial Susceptibility Testing

European Committee on Antimicrobial Susceptibility Testing European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST Version 8.0, valid from 018-01-01

More information

6.0 ANTIBACTERIAL ACTIVITY OF CAROTENOID FROM HALOMONAS SPECIES AGAINST CHOSEN HUMAN BACTERIAL PATHOGENS

6.0 ANTIBACTERIAL ACTIVITY OF CAROTENOID FROM HALOMONAS SPECIES AGAINST CHOSEN HUMAN BACTERIAL PATHOGENS 6.0 ANTIBACTERIAL ACTIVITY OF CAROTENOID FROM HALOMONAS SPECIES AGAINST CHOSEN HUMAN BACTERIAL PATHOGENS 6.1 INTRODUCTION Microorganisms that cause infectious disease are called pathogenic microbes. Although

More information

Effect of pulmonary surfactant on antimicrobial activity in-vitro

Effect of pulmonary surfactant on antimicrobial activity in-vitro AAC Accepts, published online ahead of print on 22 July 2013 Antimicrob. Agents Chemother. doi:10.1128/aac.00778-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 Effect of pulmonary

More information

Antibacterial Agents & Conditions. Stijn van der Veen

Antibacterial Agents & Conditions. Stijn van der Veen Antibacterial Agents & Conditions Stijn van der Veen Antibacterial agents & conditions Antibacterial agents Disinfectants: Non-selective antimicrobial substances that kill a wide range of bacteria. Only

More information

EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update

EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain

More information

Brief reports. Heat stability of the antimicrobial activity of sixty-two antibacterial agents

Brief reports. Heat stability of the antimicrobial activity of sixty-two antibacterial agents Journal of Antimicrobial Chemotherapy (5) 35, -5 Brief reports Heat stability of the antimicrobial activity of sixty-two antibacterial agents Walter H. Traub and Birgit Leonhard Institut fur Medizinische

More information

Antibiotic Susceptibility of Pseudomonas aeruginosa

Antibiotic Susceptibility of Pseudomonas aeruginosa ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, June 1978, p. 979-984 0066-4804/78/0013-0979$02.00/0 Copyright ) 1978 American Society for Microbiology Vol. 13, No. 6 Printed in U.S.A. Effect of Triethylenetetramine

More information

Antimicrobial agents. are chemicals active against microorganisms

Antimicrobial agents. are chemicals active against microorganisms Antimicrobial agents are chemicals active against microorganisms Antibacterial Agents Are chemicals active against bacteria Antimicrobials Antibacterial Antifungal Antiviral Antiparasitic: -anti protozoan

More information

Routine internal quality control as recommended by EUCAST Version 3.1, valid from

Routine internal quality control as recommended by EUCAST Version 3.1, valid from Routine internal quality control as recommended by EUCAST Version.1, valid from 01-01-01 Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus

More information

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to

More information

In Vitro Activity of Netilmicin, Gentamicin, and Amikacin

In Vitro Activity of Netilmicin, Gentamicin, and Amikacin ANTIMICROBIAL AGzNTS AND CHEMOTHERAPY, Jan. 1977, p. 126-131 Copyright X 1977 American Society for Microbiology Vol. 11, No. 1 Printed in U.S.A. In Vitro Activity of Netilmicin, Gentamicin, and Amikacin

More information

Determination of antibiotic sensitivities by the

Determination of antibiotic sensitivities by the Journal of Clinical Pathology, 1978, 31, 531-535 Determination of antibiotic sensitivities by the Sensititre system IAN PHILLIPS, CHRISTINE WARREN, AND PAMELA M. WATERWORTH From the Department of Microbiology,

More information

Biofilm Producing Uropathogens and Drug Resistance: Dual Foe for Patients on Urinary Catheter

Biofilm Producing Uropathogens and Drug Resistance: Dual Foe for Patients on Urinary Catheter International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 5 (2017) pp. 326-330 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.605.036

More information

An Approach to Linezolid and Vancomycin against Methicillin Resistant Staphylococcus Aureus

An Approach to Linezolid and Vancomycin against Methicillin Resistant Staphylococcus Aureus Article ID: WMC00590 ISSN 2046-1690 An Approach to Linezolid and Vancomycin against Methicillin Resistant Staphylococcus Aureus Author(s):Dr. K P Ranjan, Dr. D R Arora, Dr. Neelima Ranjan Corresponding

More information

Antimicrobial Pharmacodynamics

Antimicrobial Pharmacodynamics Antimicrobial Pharmacodynamics November 28, 2007 George P. Allen, Pharm.D. Assistant Professor, Pharmacy Practice OSU College of Pharmacy at OHSU Objectives Become familiar with PD parameters what they

More information

Principles of Anti-Microbial Therapy Assistant Professor Naza M. Ali. Lec 1

Principles of Anti-Microbial Therapy Assistant Professor Naza M. Ali. Lec 1 Principles of Anti-Microbial Therapy Assistant Professor Naza M. Ali Lec 1 28 Oct 2018 References Lippincott s IIIustrated Reviews / Pharmacology 6 th Edition Katzung and Trevor s Pharmacology / Examination

More information

Test Method Modified Association of Analytical Communities Test Method Modified Germicidal Spray Products as Disinfectants

Test Method Modified Association of Analytical Communities Test Method Modified Germicidal Spray Products as Disinfectants Study Title Antibacterial Activity and Efficacy of E-Mist Innovations' Electrostatic Sprayer Product with Multiple Disinfectants Method Modified Association of Analytical Communities Method 961.02 Modified

More information

Antimicrobial agents

Antimicrobial agents Bacteriology Antimicrobial agents Learning Outcomes: At the end of this lecture, the students should be able to: Identify mechanisms of action of antimicrobial Drugs Know and understand key concepts about

More information

The Calgary Biofilm Device: New Technology for Rapid Determination of Antibiotic Susceptibilities of Bacterial Biofilms

The Calgary Biofilm Device: New Technology for Rapid Determination of Antibiotic Susceptibilities of Bacterial Biofilms JOURNAL OF CLINICAL MICROBIOLOGY, June 1999, p. 1771 1776 Vol. 37, No. 6 0095-1137/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. The Calgary Biofilm Device: New Technology

More information

ANTIBIOTICS USED FOR RESISTACE BACTERIA. 1. Vancomicin

ANTIBIOTICS USED FOR RESISTACE BACTERIA. 1. Vancomicin ANTIBIOTICS USED FOR RESISTACE BACTERIA 1. Vancomicin Vancomycin is used to treat infections caused by bacteria. It belongs to the family of medicines called antibiotics. Vancomycin works by killing bacteria

More information

EUCAST recommended strains for internal quality control

EUCAST recommended strains for internal quality control EUCAST recommended strains for internal quality control Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus influenzae ATCC 59 ATCC

More information

GeNei TM. Antibiotic Sensitivity. Teaching Kit Manual KT Revision No.: Bangalore Genei, 2007 Bangalore Genei, 2007

GeNei TM. Antibiotic Sensitivity. Teaching Kit Manual KT Revision No.: Bangalore Genei, 2007 Bangalore Genei, 2007 GeNei Bacterial Antibiotic Sensitivity Teaching Kit Manual Cat No. New Cat No. KT68 106333 Revision No.: 00180705 CONTENTS Page No. Objective 3 Principle 3 Kit Description 4 Materials Provided 5 Procedure

More information

PILOT STUDY OF THE ANTIMICROBIAL SUSCEPTIBILITY OF SHIGELLA IN NEW ZEALAND IN 1996

PILOT STUDY OF THE ANTIMICROBIAL SUSCEPTIBILITY OF SHIGELLA IN NEW ZEALAND IN 1996 PILOT STUDY OF THE ANTIMICROBIAL SUSCEPTIBILITY OF SHIGELLA IN NEW ZEALAND IN 996 November 996 by Maggie Brett Antibiotic Reference Laboratory ESR Communicable Disease Centre Porirua CONTENTS Page SUMMARY

More information

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents Burton's Microbiology for the Health Sciences Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents Chapter 9 Outline Introduction Characteristics of an Ideal Antimicrobial Agent How

More information

EXPERIMENT. Antibiotic Sensitivity-Kirby Bauer Diffusion Test

EXPERIMENT. Antibiotic Sensitivity-Kirby Bauer Diffusion Test EXPERIMENT Antibiotic Sensitivity-Kirby Bauer Diffusion Test Author Name Version 42-0238-00-02 Review the safety materials and wear goggles when working with chemicals. Read the entire exercise before

More information

Introduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018

Introduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018 Introduction to Chemotherapeutic Agents Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018 Antimicrobial Agents Substances that kill bacteria without harming the host.

More information

ETX2514SUL (sulbactam/etx2514) for the treatment of Acinetobacter baumannii infections

ETX2514SUL (sulbactam/etx2514) for the treatment of Acinetobacter baumannii infections ETX2514SUL (sulbactam/etx2514) for the treatment of Acinetobacter baumannii infections Robin Isaacs Chief Medical Officer, Entasis Therapeutics Dr. Isaacs is a full-time employee of Entasis Therapeutics.

More information

Swarnatrisha Saha*, Ksh Mamta Devi, Shan Damrolien, Kh. Sulochana Devi, Krossnunpuii, Kongbrailatpam Tharbendra Sharma

Swarnatrisha Saha*, Ksh Mamta Devi, Shan Damrolien, Kh. Sulochana Devi, Krossnunpuii, Kongbrailatpam Tharbendra Sharma International Journal of Advances in Medicine Saha S et al. Int J Adv Med. 2018 Aug;5(4):964-968 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20183129

More information

Evaluation of MicroScan MIC Panels for Detection of

Evaluation of MicroScan MIC Panels for Detection of JOURNAL OF CLINICAL MICROBIOLOGY, May 1988, p. 816-820 Vol. 26, No. 5 0095-1137/88/050816-05$02.00/0 Copyright 1988, American Society for Microbiology Evaluation of MicroScan MIC Panels for Detection of

More information

Antibiotics & Resistance

Antibiotics & Resistance What are antibiotics? Antibiotics & esistance Antibiotics are molecules that stop bacteria from growing or kill them Antibiotics, agents against life - either natural or synthetic chemicals - designed

More information

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

PDF hosted at the Radboud Repository of the Radboud University Nijmegen PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/26062

More information

Detection of Methicillin Resistant Strains of Staphylococcus aureus Using Phenotypic and Genotypic Methods in a Tertiary Care Hospital

Detection of Methicillin Resistant Strains of Staphylococcus aureus Using Phenotypic and Genotypic Methods in a Tertiary Care Hospital International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 7 (2017) pp. 4008-4014 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.607.415

More information

Management of Native Valve

Management of Native Valve Management of Native Valve Infective Endocarditis 2005 AHA 2015 Baddour LM, et al. Circulation. 2015;132(15):1435-86 2009 ESC 2015 Habib G, et al. Eur Heart J. 2015;36(44):3075-128 ESC 2015: Endocarditis

More information

Original Article. Ratri Hortiwakul, M.Sc.*, Pantip Chayakul, M.D.*, Natnicha Ingviya, B.Sc.**

Original Article. Ratri Hortiwakul, M.Sc.*, Pantip Chayakul, M.D.*, Natnicha Ingviya, B.Sc.** Original Article In Vitro Activity of Cefminox and Other β-lactam Antibiotics Against Clinical Isolates of Extended- Spectrum-β-lactamase-Producing Klebsiella pneumoniae and Escherichia coli Ratri Hortiwakul,

More information

There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility

There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility ANTIMICROBIAL SUSCEPTIBILITY TESTING ON MILK SAMPLES Method and guidelines There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility

More information

56 Clinical and Laboratory Standards Institute. All rights reserved.

56 Clinical and Laboratory Standards Institute. All rights reserved. Table 2C 56 Clinical and Laboratory Standards Institute. All rights reserved. Table 2C. Zone Diameter and Minimal Inhibitory Concentration Breakpoints for Testing Conditions Medium: Inoculum: diffusion:

More information

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2. AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony

More information

IN VITRO COMBINATION EFFECTS OF NORFLOXACIN, GENTAMICIN, AND Ĉ- LACTAMS ON Ĉ- LACTAM RESISTANT PSEUDOMONAS AERUGINOSA

IN VITRO COMBINATION EFFECTS OF NORFLOXACIN, GENTAMICIN, AND Ĉ- LACTAMS ON Ĉ- LACTAM RESISTANT PSEUDOMONAS AERUGINOSA IN VITRO COMBINATION EFFECTS OF NORFLOXACIN, GENTAMICIN, AND Ĉ- LACTAMS ON Ĉ- LACTAM RESISTANT PSEUDOMONAS AERUGINOSA YONGYUTH JITTAROPAS NAOTO 1), RIKITOMI 2), and Kaizo MATSUMOTO 2) 1) Department of

More information

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC MICRONAUT Detection of Resistance Mechanisms Innovation with Integrity BMD MIC Automated and Customized Susceptibility Testing For detection of resistance mechanisms and specific resistances of clinical

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Quality Assurance of antimicrobial susceptibility testing Derek Brown EUCAST Scientific Secretary ESCMID Postgraduate Education Course, Linz, 17 September 2014 Quality Assurance The total process by which

More information

Inhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani

Inhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani Inhibiting Microbial Growth in vivo CLS 212: Medical Microbiology Zeina Alkudmani Chemotherapy Definitions The use of any chemical (drug) to treat any disease or condition. Chemotherapeutic Agent Any drug

More information

What s new in EUCAST methods?

What s new in EUCAST methods? What s new in EUCAST methods? Derek Brown EUCAST Scientific Secretary Interactive question 1 MIC determination MH-F broth for broth microdilution testing of fastidious microorganisms Gradient MIC tests

More information

JAC Linezolid against penicillin-sensitive and -resistant pneumococci in the rabbit meningitis model

JAC Linezolid against penicillin-sensitive and -resistant pneumococci in the rabbit meningitis model Journal of Antimicrobial Chemotherapy (2000) 46, 981 985 JAC Linezolid against penicillin-sensitive and -resistant pneumococci in the rabbit meningitis model Philippe Cottagnoud a *, Cynthia M. Gerber

More information

Synergy of Daptomycin with Oxacillin and Other -Lactams against Methicillin-Resistant Staphylococcus aureus

Synergy of Daptomycin with Oxacillin and Other -Lactams against Methicillin-Resistant Staphylococcus aureus ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 2004, p. 2871 2875 Vol. 48, No. 8 0066-4804/04/$08.00 0 DOI: 10.1128/AAC.48.8.2871 2875.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved.

More information

Aerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune

Aerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune Original article Aerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune Patil P, Joshi S, Bharadwaj R. Department of Microbiology, B.J. Medical College, Pune, India. Corresponding

More information

Chapter 51. Clinical Use of Antimicrobial Agents

Chapter 51. Clinical Use of Antimicrobial Agents Chapter 51 Clinical Use of Antimicrobial Agents History of antimicrobial therapy Early 17 th century Cinchona bark was used as an important historical remedy against malaria. 1909 Paul Ehrlich sought a

More information

Aminoglycoside-resistant enterococci

Aminoglycoside-resistant enterococci Aminoglycoside-resistant enterococci M. J. BASKER, B. SLOCOMBE, AND R. SUTHERLAND From Beecham Pharmaceuticals Research Division, Brockham Park, Betchworth, Surrey J. clin. Path., 1977, 30, 375-380 SUMMARY

More information

Comparative Activity of Netilmicin, Gentamicin, Amikacin, and Tobramycin Against Pseudomonas aeruginosa and Enterobacteriaceae

Comparative Activity of Netilmicin, Gentamicin, Amikacin, and Tobramycin Against Pseudomonas aeruginosa and Enterobacteriaceae ANTIMICROBIAL AGzNTS AND CHEMOTHERAPY, Oct. 1976, P. 592-597 Copyright 1976 American Society for Microbiology Vol. 1, No. 4 Printed in U.S.A. Comparative Activity of Netilmicin, Gentamicin, Amikacin, and

More information

Detection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran

Detection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran Letter to the Editor Detection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran Mohammad Rahbar, PhD; Massoud Hajia, PhD

More information

Pharm 262: Antibiotics. 1 Pharmaceutical Microbiology II DR. C. AGYARE

Pharm 262: Antibiotics. 1 Pharmaceutical Microbiology II DR. C. AGYARE Pharm 262: 1 Pharmaceutical Microbiology II Antibiotics DR. C. AGYARE Reference Books 2 HUGO, W.B., RUSSELL, A.D. Pharmaceutical Microbiology. 6 th Ed. Malden, MA: Blackwell Science, 1998. WALSH, G. Biopharmaceuticals:

More information

The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place? Paul M. Tulkens

The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place? Paul M. Tulkens The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place? Paul M. Tulkens Cellular and Molecular Pharmacology Unit Catholic University of Louvain, Brussels,

More information

RESISTANCE OF STAPHYLOCOCCUS AUREUS TO VANCOMYCIN IN ZARQA, JORDAN

RESISTANCE OF STAPHYLOCOCCUS AUREUS TO VANCOMYCIN IN ZARQA, JORDAN RESISTANCE OF STAPHYLOCOCCUS AUREUS TO VANCOMYCIN IN ZARQA, JORDAN Hussein Azzam Bataineh 1 ABSTRACT Background: Vancomycin has been widely used in the treatment of infections caused by Methicillin-Resistant

More information

number Done by Corrected by Doctor Dr Hamed Al-Zoubi

number Done by Corrected by Doctor Dr Hamed Al-Zoubi number 8 Done by Corrected by Doctor Dr Hamed Al-Zoubi 25 10/10/2017 Antibacterial therapy 2 د. حامد الزعبي Dr Hamed Al-Zoubi Antibacterial therapy Figure 2/ Antibiotics target Inhibition of microbial

More information

What is new in 2011: Methods and breakpoints in relation to subcommittees and expert groups. by author. Gunnar Kahlmeter, Derek Brown

What is new in 2011: Methods and breakpoints in relation to subcommittees and expert groups. by author. Gunnar Kahlmeter, Derek Brown What is new in 2011: Methods and breakpoints in relation to subcommittees and expert groups Gunnar Kahlmeter, Derek Brown Izmir, February 2011 Anaerobes subcommittee EUCAST Subcommittee on breakpoints

More information

Factors affecting plate assay of gentamicin

Factors affecting plate assay of gentamicin Journal of Antimicrobial Chemotherapy (1977) 3, 17-23 Factors affecting plate assay of gentamicin II. Media D. C. Shanson* and C. J. Hince Department of Medical Microbiology, The London Hospital Medical

More information

Efficacy of combination oral antimicrobial agents against biofilm-embedded methicillin-resistant Staphylococcus aureus

Efficacy of combination oral antimicrobial agents against biofilm-embedded methicillin-resistant Staphylococcus aureus Journal of Microbiology, Immunology and Infection (2013) 46, 89e95 Available online at www.sciencedirect.com journal homepage: www.e-jmii.com ORIGINAL ARTICLE Efficacy of combination oral antimicrobial

More information

Laboratório de Resistência Bacteriana, Departamento de Patologia, Universidade Federal do Espírito Santo, Vitória, ES, Brasil 2

Laboratório de Resistência Bacteriana, Departamento de Patologia, Universidade Federal do Espírito Santo, Vitória, ES, Brasil 2 44 Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 106(1): 44-50, February 2011 Evaluation of the synergistic potential of vancomycin combined with other antimicrobial agents against methicillin-resistant

More information

Introduction to Antimicrobials. Lecture Aim: To provide a brief introduction to antibiotics. Future lectures will go into more detail.

Introduction to Antimicrobials. Lecture Aim: To provide a brief introduction to antibiotics. Future lectures will go into more detail. Introduction to Antimicrobials Rachel J. Gordon, MD, MPH Lecture Aim: To provide a brief introduction to antibiotics. Future lectures will go into more detail. Major Learning Objectives: 1) Learn the different

More information

Outline. Antimicrobial resistance. Antimicrobial resistance in gram negative bacilli. % susceptibility 7/11/2010

Outline. Antimicrobial resistance. Antimicrobial resistance in gram negative bacilli. % susceptibility 7/11/2010 Multi-Drug Resistant Organisms Is Combination Therapy the Way to Go? Sutthiporn Pattharachayakul, PharmD Prince of Songkhla University, Thailand Outline Prevalence of anti-microbial resistance in Acinetobacter

More information

EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING

EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING CHN61: EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING 1.1 Introduction A common mechanism of bacterial resistance to beta-lactam antibiotics is the production

More information

Chapter 2. Disk diffusion method

Chapter 2. Disk diffusion method Chapter 2. Disk diffusion method Tendencia, Eleonor A. Date published: 2004 To cite this document : Tendencia, E. A. (2004). Chapter 2. Disk diffusion method. In Laboratory manual of standardized methods

More information

Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance

Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance evolution of antimicrobial resistance Mechanism of bacterial genetic variability Point mutations may occur in a nucleotide base pair,

More information

Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method.

Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method. Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method. OBJECTIVES 1. Compare the antimicrobial capabilities of different antibiotics. 2. Compare effectiveness of with different types of bacteria.

More information

Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems

Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems Micro 301 Antimicrobial Drugs 11/7/12 Significance of antimicrobial drugs Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems Definitions Antibiotic Selective

More information

Intrinsic, implied and default resistance

Intrinsic, implied and default resistance Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been

More information

Pharmacological Evaluation of Amikacin in Neonates

Pharmacological Evaluation of Amikacin in Neonates ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, JUlY 1975, p. 86-90 Copyright 0 1975 American Society for Microbiology Vol. 8, No. 1 Printed in U.SA. Pharmacological Evaluation of Amikacin in Neonates JORGE B.

More information

In Vitro Antimicrobial Activity of CP-99,219, a Novel Azabicyclo-Naphthyridone

In Vitro Antimicrobial Activity of CP-99,219, a Novel Azabicyclo-Naphthyridone ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 993, p. 39-353 0066-0/93/0039-05$0.00/0 Copyright 993, American Society for Microbiology Vol. 37, No. In Vitro Antimicrobial Activity of, a Novel Azabicyclo-Naphthyridone

More information

Zyvox. Zyvox (linezolid) Description

Zyvox. Zyvox (linezolid) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.01.20 Subject: Zyvox Page: 1 of 7 Last Review Date: March 18, 2016 Zyvox Description Zyvox (linezolid)

More information